Stock Events

Stock Events

Achilles Therapeutics (ACHL) Q2 2023 Earnings

4AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.61

-0.51

-0.42

-0.32

Details

Expected EPS

-0.42

Actual EPS

-0.42

Surprise EPS

0

Surprise Percent

+0%

Description

Achilles Therapeutics (ACHL) has reported earnings of -0.42 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.